L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease.
about
The reduced expression of the HADH2 protein causes X-linked mental retardation, choreoathetosis, and abnormal behaviorA non-enzymatic function of 17beta-hydroxysteroid dehydrogenase type 10 is required for mitochondrial integrity and cell survival.Enhancement of L-3-hydroxybutyryl-CoA dehydrogenase activity and circulating ketone body levels by pantethine. Relevance to dopaminergic injury.PINK1/Parkin-Dependent Mitochondrial Surveillance: From Pleiotropy to Parkinson's Disease.Alzheimer's proteins, oxidative stress, and mitochondrial dysfunction interplay in a neuronal model of Alzheimer's disease.Parkin maintains mitochondrial levels of the protective Parkinson's disease-related enzyme 17-β hydroxysteroid dehydrogenase type 10Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD).Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardationIs amyloid binding alcohol dehydrogenase a drug target for treating Alzheimer's disease?The consequences of mitochondrial amyloid beta-peptide in Alzheimer's disease.HSD10 disease: clinical consequences of mutations in the HSD17B10 gene.Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity.Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.Investigation into experimental toxicological properties of plant protection products having a potential link to Parkinson's disease and childhood leukaemia†Mitochondrial β-amyloid in Alzheimer's disease.Levels of 17β-Hydroxysteroid Dehydrogenase Type 10 in Cerebrospinal Fluid of People with Mild Cognitive Impairment and Various Types of Dementias.
P2860
Q24680417-AD8829AA-BF87-4947-A853-2DFDF898BDC7Q30981928-29C388A4-F77C-4120-ADF5-02090600B02BQ33563284-11699C85-1455-40DC-ADEA-95E504AF774CQ33619324-EA04AB35-2DCE-4379-8ED4-C3768A908CF6Q34127614-D7B03B2C-5057-4FBF-B6AE-F28640AA8337Q36040571-B957E874-FC44-4EDA-B3D3-E6DCE758A692Q36135523-4022BAC3-E0D2-40CD-B286-213D5015D60EQ36718273-4C93568F-8513-4088-BD6C-1360496E040CQ36908481-EC7233D9-1F2C-4663-A8EF-47C4DB0E0AA1Q37696521-53C6DC6C-A841-484E-A8E5-D1ADD615D873Q37962802-9864D2CB-DF3D-4CD5-993F-C042720E46A9Q43090705-BE0AC115-E244-49FD-A30F-6B61364B2D7DQ43162071-E6833148-3E17-4D3B-8E1F-345DA694F9C2Q47159009-65FF7EF6-1076-4FBE-9633-1CAD051394D3Q49015269-627EB67B-EEBC-4654-BA07-C6EEC14D4311Q50563468-6BF28ECE-20A9-4377-8607-EA871195ACF3
P2860
L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease.
@en
L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease.
@nl
type
label
L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease.
@en
L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease.
@nl
prefLabel
L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease.
@en
L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease.
@nl
P2093
P50
P356
P1433
P1476
L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease.
@en
P2093
Casper Caspersen
Celine Perier
David M Stern
Hui-Ping Zhang
Peter Teismann
Shi Du Yan
P2860
P356
10.1002/ANA.20133
P577
2004-07-01T00:00:00Z